199 related articles for article (PubMed ID: 35811521)
1. Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-β, and Cerebral Atrophy.
Chia SY; Vipin A; Ng KP; Tu H; Bommakanti A; Wang BZ; Tan YJ; Zailan FZ; Ng ASL; Ling SC; Okamura K; Tan EK; Kandiah N; Zeng L
J Alzheimers Dis; 2022; 88(4):1567-1584. PubMed ID: 35811521
[TBL] [Abstract][Full Text] [Related]
2. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease.
Jia L; Zhu M; Yang J; Pang Y; Wang Q; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y
BMC Med; 2021 Nov; 19(1):264. PubMed ID: 34775974
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
4. Beyond CSF and Neuroimaging Assessment: Evaluating Plasma miR-145-5p as a Potential Biomarker for Mild Cognitive Impairment and Alzheimer's Disease.
Wen Q; Wittens MMJ; Engelborghs S; van Herwijnen MHM; Tsamou M; Roggen E; Smeets B; Krauskopf J; Briedé JJ
ACS Chem Neurosci; 2024 Mar; 15(5):1042-1054. PubMed ID: 38407050
[TBL] [Abstract][Full Text] [Related]
5. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim SY; Park YH; Nho K
Alzheimers Res Ther; 2024 Jan; 16(1):5. PubMed ID: 38195609
[TBL] [Abstract][Full Text] [Related]
6. Human microRNA (miR-20b-5p) modulates Alzheimer's disease pathways and neuronal function, and a specific polymorphism close to the MIR20B gene influences Alzheimer's biomarkers.
Wang R; Chopra N; Nho K; Maloney B; Obukhov AG; Nelson PT; Counts SE; Lahiri DK
Mol Psychiatry; 2022 Feb; 27(2):1256-1273. PubMed ID: 35087196
[TBL] [Abstract][Full Text] [Related]
7. Profile of Pathogenic Proteins and MicroRNAs in Plasma-derived Extracellular Vesicles in Alzheimer's Disease: A Pilot Study.
Li F; Xie XY; Sui XF; Wang P; Chen Z; Zhang JB
Neuroscience; 2020 Apr; 432():240-246. PubMed ID: 32135232
[TBL] [Abstract][Full Text] [Related]
8. Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology.
Sierksma A; Lu A; Salta E; Vanden Eynden E; Callaerts-Vegh Z; D'Hooge R; Blum D; Buée L; Fiers M; De Strooper B
Mol Neurodegener; 2018 Oct; 13(1):54. PubMed ID: 30314521
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-455-3p as a potential peripheral biomarker for Alzheimer's disease.
Kumar S; Vijayan M; Reddy PH
Hum Mol Genet; 2017 Oct; 26(19):3808-3822. PubMed ID: 28934394
[TBL] [Abstract][Full Text] [Related]
10. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
11. Altered Cerebrospinal Fluid Exosomal microRNA Levels in Young-Onset Alzheimer's Disease and Frontotemporal Dementia.
Tan YJ; Wong BYX; Vaidyanathan R; Sreejith S; Chia SY; Kandiah N; Ng ASL; Zeng L
J Alzheimers Dis Rep; 2021; 5(1):805-813. PubMed ID: 34870106
[TBL] [Abstract][Full Text] [Related]
12. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
Wang D; Fei Z; Luo S; Wang H
Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
14. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
Cosín-Tomás M; Antonell A; Lladó A; Alcolea D; Fortea J; Ezquerra M; Lleó A; Martí MJ; Pallàs M; Sanchez-Valle R; Molinuevo JL; Sanfeliu C; Kaliman P
Mol Neurobiol; 2017 Sep; 54(7):5550-5562. PubMed ID: 27631879
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
16. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA miR-212 regulates PDCD4 to attenuate Aβ
Wang Y; Chang Q
Biotechnol Lett; 2020 Sep; 42(9):1789-1797. PubMed ID: 32474742
[TBL] [Abstract][Full Text] [Related]
18. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
19. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
20. miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's disease.
Han SW; Pyun JM; Bice PJ; Bennett DA; Saykin AJ; Kim S; Park YH; Nho K
Res Sq; 2023 Nov; ():. PubMed ID: 37961387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
